Showing results (201-210 of 219) with videos related to
Sort By:
Pageof 22
The Lancet. Oncology|October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyMrinal Gounder, Patrick Schöffski, Robin L Jones, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2024
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient TumorsJ Andrew Livingston, Jean-Yves Blay, Jonathan Trent, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2026
Combination of Lurbinectedin plus Irinotecan: Preclinical and Early Clinical Results in Relapsed Small Cell Lung Cancer PatientsSantiago Ponce, Miguel Ruiz-Torres, Alejandro Falcón, et al.Life Science Alliance|December 28, 2020
The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependenciesGaylor Boulay, Luisa Cironi, Sara P Garcia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG OncologyAaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.Pediatric Blood & Cancer|June 22, 2023
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumorLiny John, Hannah Smith, Maran Ilanchezhian, et al.Neuro-Oncology|December 19, 2025
Prospective, Randomized Dose Escalation Trial with Proton-Based Radiation for Skull Base and Cervical Spine Chondrosarcomas: 30-year outcomes from PROG 85-26Myrsini Ioakeim-Ioannidou, Beow Y Yeap, Zainab O Soetan, et al.Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021Margaret von Mehren, John M Kane, Marilyn M Bui, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022Margaret von Mehren, John M Kane, Richard F Riedel, et al.Pageof 22